Literature DB >> 18373415

Successful rescue therapy with Raltegravir (MK-0518) and Etravirine (TMC125) in an hiv-infected patient failing all four classes of antiretroviral drugs.

Antonio Di Biagio1, Bianca Bruzzone, Raffaella Rosso, Ottavia Viganò, Giancarlo Icardi, Claudio Viscoli, Stefano Rusconi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18373415     DOI： 10.1089/apc.2007.0215

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN： 1087-2914            Impact factor:   5.078


× No keyword cloud information.
  3 in total

1.  Canadian consensus guidelines for the optimal use of etravirine in the treatment of HIV-infected adults.

Authors:  Marianne Harris; Jonathan B Angel; Jean-Guy Baril; Anita Rachlis; Benoit Trottier
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

2.  Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection.

Authors:  Hans-Jürgen Stellbrink
Journal:  Core Evid       Date:  2010-06-15

3.  HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients.

Authors:  Antonio Piralla; Stefania Paolucci; Roberto Gulminetti; Giuditta Comolli; Fausto Baldanti
Journal:  Virol J       Date:  2011-03-31       Impact factor: 4.099
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.